These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17994243)

  • 1. [Clinical risk-adapted therapies in systemic sclerosis].
    Riemekasten G; Dragun D
    Z Rheumatol; 2007 Dec; 66(8):672-4, 676-8. PubMed ID: 17994243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of scleroderma.
    Sapadin AN; Fleischmajer R
    Arch Dermatol; 2002 Jan; 138(1):99-105. PubMed ID: 11790173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic sclerosis].
    Peltomaa R; Pettersson T; Tuompo R; Luosujärvi R
    Duodecim; 2013; 129(19):1981-91. PubMed ID: 24218729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic sclerosis : What is currently available for treatment?].
    Becker MO
    Internist (Berl); 2016 Dec; 57(12):1155-1163. PubMed ID: 27796473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus.
    Khorshid O; Hosing C; Bibawi S; Ueno N; Reveille J; Mayes MD; Champlin RE
    J Rheumatol; 2004 Dec; 31(12):2513-6. PubMed ID: 15570660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and therapy for systemic sclerosis].
    Umehara H; Tanaka M; Masaki Y; Fukushima T
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2165-70. PubMed ID: 18044151
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease-modifying treatment in systemic sclerosis: current status.
    Quillinan NP; Denton CP
    Curr Opin Rheumatol; 2009 Nov; 21(6):636-41. PubMed ID: 19726995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.
    Tan A; Denton CP; Mikhailidis DP; Seifalian AM
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S66-74. PubMed ID: 21586221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis - focus on dermatological aspects. Part 2: diagnostics, therapy.
    Sticherling M
    J Dtsch Dermatol Ges; 2012 Nov; 10(11):783-91. PubMed ID: 23107322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating systemic sclerosis in 2001.
    Mouthon L; Agard C
    Joint Bone Spine; 2001 Oct; 68(5):393-402. PubMed ID: 11707005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in pathogenesis and treatment of systemic sclerosis.
    Denton CP
    Clin Med (Lond); 2016 Feb; 16(1):55-60. PubMed ID: 26833515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the diagnosis and treatment of systemic sclerosis.
    Kowal-Bielecka O; Bielecki M; Kowal K
    Pol Arch Med Wewn; 2013; 123(1-2):51-8. PubMed ID: 23344666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic strategies in scleroderma.
    Denton CP; Black CM
    Curr Rheumatol Rep; 1999 Oct; 1(1):22-7. PubMed ID: 11123010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of scleroderma: an update.
    Sule SD; Wigley FM
    Expert Opin Investig Drugs; 2003 Mar; 12(3):471-82. PubMed ID: 12605568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of patients with systemic sclerosis].
    Wiesik-Szewczyk E; Olesińska M
    Pol Merkur Lekarski; 2010 May; 28(167):421-3. PubMed ID: 20568411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose immunosuppressive therapy and autologous progenitor cell transplantation for systemic sclerosis.
    van Laar JM; McSweeney PA
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):233-45. PubMed ID: 15302337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease in systemic sclerosis: current and future treatment.
    Giacomelli R; Liakouli V; Berardicurti O; Ruscitti P; Di Benedetto P; Carubbi F; Guggino G; Di Bartolomeo S; Ciccia F; Triolo G; Cipriani P
    Rheumatol Int; 2017 Jun; 37(6):853-863. PubMed ID: 28063071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis.
    Scherer HU; Burmester GR; Riemekasten G
    Ann Rheum Dis; 2006 Sep; 65(9):1245-7. PubMed ID: 16905582
    [No Abstract]   [Full Text] [Related]  

  • 19. [Physiopathology and therapy of progressive systemic sclerosis].
    Kondo H
    Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):412-6. PubMed ID: 9577567
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
    Hasegawa M; Takehara K
    Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.